デフォルト表紙
市場調査レポート
商品コード
1015988

遠隔医療市場:世界的予測、COVID-19の影響、業界動向、成長、機会、企業概要、財務動向

Telemedicine Market, Global Forecast Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Financial Insight

出版日: | 発行: Renub Research | ページ情報: 英文 150 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.12円
遠隔医療市場:世界的予測、COVID-19の影響、業界動向、成長、機会、企業概要、財務動向
出版日: 2021年06月01日
発行: Renub Research
ページ情報: 英文 150 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遠隔医療は、ICT(情報通信技術)を利用して国際的な障壁を取り除き、医療サービスへのアクセスを急増させる技術です。この技術は、伝統的に医療サービスの恩恵を受けられない発展途上国の農村部やサービスの行き届いていないコミュニティに主に恩恵をもたらします。ICTは、先進国と発展途上国の両方が直面している、質の高いヘルスケアサービスをよりコスト効率よく提供するためのハードルを解決する大きな可能性を秘めています。当社の分析によると、世界の遠隔医療の市場規模は、2026年までに2,184億9,000万米ドルまで成長すると予測されています。

遠隔医療市場の主要プレイヤーは、2019年と比較してCOVID-19のパンデミック時に急激な成長を遂げています。

米国に本社を置くSOC Telemed社は、遠隔医療技術とサービスを取り扱っており、2020年、COVID期間に同社の収益が急増したと述べています。

Teladoc Health Inc Companyの収益もCOVID-19のパンデミックにより増加しました。

当レポートでは、遠隔医療市場について調査し、市場の概要とともに、タイプ別、用途別、モダリティ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長要因
  • 課題

第5章 世界の遠隔医療市場

第6章 市場シェア

  • タイプ別
  • 用途別
  • モダリティ別
  • エンドユーザー別
  • 地域別

第7章 世界の遠隔医療市場、タイプ別

  • 製品
  • サービス

第8章 世界の遠隔医療市場、用途別

  • テレコンサルテーション
  • テレパソロジー
  • 心電図
  • 遠隔手術
  • 遠隔放射線学
  • 遠隔皮膚科学
  • 遠隔精神医学
  • その他

第9章 世界の遠隔医療市場、モダリティ別

  • リアルタイム遠隔医療
  • リモート患者モニタリング

第10章 世界の遠隔医療市場、エンドユーザー別

  • 病院
  • 診断センター
  • 通院外科診療所(ASC)
  • 専門センター
  • その他

第11章 世界の遠隔医療市場、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東とアフリカ

第12章 企業分析

  • CEVA, Inc.
    • 概要
    • 最近の開発と戦略
    • 財務動向
  • Eli Lilly and Company
    • 概要
    • 最近の開発と戦略
    • 財務動向
  • Bayer AG
    • 概要
    • 最近の開発と戦略
    • 財務動向
  • Merck & Co. Inc
    • 概要
    • 最近の開発と戦略
    • 財務動向
  • Teladoc Health, Inc.
    • 概要
    • 最近の開発と戦略
    • 財務動向
図表

List of Figures

Figure-01: Global Telemedicine Market (Billion US$), 2016 - 2020

Figure-02: Forecast for - Global Telemedicine Market (Billion US$), 2021 - 2026

Figure-03: Types - Products Market (Billion US$), 2016 - 2020

Figure-04: Types - Forecast for Products Market (Billion US$), 2021 - 2026

Figure-05: Types - Services Market (Billion US$), 2016 - 2020

Figure-06: Types - Forecast for Services Market (Billion US$), 2021 - 2026

Figure-07: Application - Teleconsultation Market (Billion US$), 2016 - 2020

Figure-08: Application - Forecast for Teleconsultation Market (Billion US$), 2021 - 2026

Figure-09: Application - Telepathology Market (Billion US$), 2016 - 2020

Figure-10: Application - Forecast for Telepathology Market (Billion US$), 2021 - 2026

Figure-11: Application - Telecardiology Market (Billion US$), 2016 - 2020

Figure-12: Application - Forecast for Telecardiology Market (Billion US$), 2021 - 2026

Figure-13: Application - Telesurgery Market (Billion US$), 2016 - 2020

Figure-14: Application - Forecast for Telesurgery Market (Billion US$), 2021 - 2026

Figure-15: Application - Teleradiology Market (Billion US$), 2016 - 2020

Figure-16: Application - Forecast for Teleradiology Market (Billion US$), 2021 - 2026

Figure-17: Application - Teledermatology Market (Billion US$), 2016 - 2020

Figure-18: Application - Forecast for Teledermatology Market (Billion US$), 2021 - 2026

Figure-19: Application - Telepsychiatry Market (Billion US$), 2016 - 2020

Figure-20: Application - Forecast for Telepsychiatry Market (Billion US$), 2021 - 2026

Figure-21: Application - Others Market (Billion US$), 2016 - 2020

Figure-22: Application - Forecast for Others Market (Billion US$), 2021 - 2026

Figure-23: Modality - Real Time Telemedicine Market (Billion US$), 2016 - 2020

Figure-24: Modality - Forecast for Real Time Telemedicine Market (Billion US$), 2021 - 2026

Figure-25: Modality - Remote Patient Monitoring Market (Billion US$), 2016 - 2020

Figure-26: Modality - Forecast for Remote Patient Monitoring Market (Billion US$), 2021 - 2026

Figure-27: End User - Hospital Market (Billion US$), 2016 - 2020

Figure-28: End User - Forecast for Hospital Market (Billion US$), 2021 - 2026

Figure-29: End User - Diagnostic Center Market (Billion US$), 2016 - 2020

Figure-30: End User - Forecast for Diagnostic Center Market (Billion US$), 2021 - 2026

Figure-31: End User - Ambulatory Surgical Center Market (Billion US$), 2016 - 2020

Figure-32: End User - Forecast for Ambulatory Surgical Center Market (Billion US$), 2021 - 2026

Figure-33: End User - Specialty Center Market (Billion US$), 2016 - 2020

Figure-34: End User - Forecast for Specialty Center Market (Billion US$), 2021 - 2026

Figure-35: End User - Others Market (Billion US$), 2016 - 2020

Figure-36: End User - Forecast for Others Market (Billion US$), 2021 - 2026

Figure-37: North America - Telemedicine Market (Billion US$), 2016 - 2020

Figure-38: North America - Forecast for Telemedicine Market (Billion US$), 2021 - 2026

Figure-39: Europe - Telemedicine Market (Billion US$), 2016 - 2020

Figure-40: Europe - Forecast for Telemedicine Market (Billion US$), 2021 - 2026

Figure-41: Asia Pacific - Telemedicine Market (Billion US$), 2016 - 2020

Figure-42: Asia Pacific - Forecast for Telemedicine Market (Billion US$), 2021 - 2026

Figure-43: Latin America - Telemedicine Market (Billion US$), 2016 - 2020

Figure-44: Latin America - Forecast for Telemedicine Market (Billion US$), 2021 - 2026

Figure-45: Middle East & Africa - Telemedicine Market (Billion US$), 2016 - 2020

Figure-46: Middle East & Africa - Forecast for Telemedicine Market (Billion US$), 2021 - 2026

Figure-47: CEVA, Inc. - Global Revenue (Million US$), 2016 - 2020

Figure-48: CEVA, Inc. - Forecast for Global Revenue (Million US$), 2021 - 2026

Figure-49: Eli Lilly and Company - Global Revenue (Billion US$), 2016 - 2020

Figure-50: Eli Lilly and Company - Forecast for Global Revenue (Billion US$), 2021 - 2026

Figure-51: Bayer AG - Global Revenue (Billion US$), 2016 - 2020

Figure-52: Bayer AG - Forecast for Global Revenue (Billion US$), 2021 - 2026

Figure-53: Merck & Co. Inc - Global Revenue (Billion US$), 2016 - 2020

Figure-54: Merck & Co. Inc - Forecast for Global Revenue (Billion US$), 2021 - 2026

Figure-55: Teladoc Health, Inc. - Global Revenue (Million US$), 2016 - 2020

Figure-56: Teladoc Health, Inc. - Forecast for Global Revenue (Million US$), 2021 - 2026

List of Tables

Table-01: Global - Telemedicine Market Share by Types (Percent), 2016 - 2020

Table-02: Global - Forecast for Telemedicine Market Share by Types (Percent), 2021 - 2026

Table-03: Global - Telemedicine Market Share by Application (Percent), 2016 - 2020

Table-04: Global - Forecast for Telemedicine Market Share by Application (Percent), 2021 - 2026

Table-05: Global - Telemedicine Market Share by Countries (Percent), 2016 - 2020

Table-06: Global - Forecast for Telemedicine Market Share by Countries (Percent), 2021 - 2026

Table-07: Global - Cyber Security Market Share by End User (Percent), 2016 - 2020

Table-08: Global - Forecast for Cyber Security Market Share by End User (Percent), 2021 - 2026

Table-09: Global - Cyber Security Market Share by Region (Percent), 2016 - 2020

Table-10: Global - Forecast for Cyber Security Market Share by Region (Percent), 2021 - 2026

目次

Telemedicine uses ICTs (Information and communication technologies) to control international barriers and surge access to health care services. This technology mainly benefits rural and underserved communities in developing nations - groups traditionally suffer from a lack of benefits to health care services. ICTs have great potential to address the hurdles faced by both developed and developing nations in providing quality health care services and more cost-effective. As per our analysis, the Global Telemedicine Market projected to grow up to US$ 218.49 Billion by 2026.

Key players in the telemedicine market have experienced exponential growth during the COVID-19 pandemic compared to 2019.

United States-based company SOC Telemed deals in telemedicine technology and services, stated that in 2020, the company's revenue surged in COVID period.

Teladoc Health Inc Company's revenue also increased due to the COVID-19 pandemic.

In China, companies like WeChat, TikTok, Weibo came together in the pandemic. They helped mental health professionals, health care bodies to provide safe health services online through mental health surveys and communication programmes.

Today, the advancement in technology has further triggered the government to develop regulations and reimbursement policies revolving around telehealth. Thereon, developments in the telemedicine industry have made healthcare affordable and accessible to all. The market endures many opportunities to grow during the forecast period. The market is owing to the lack of access to care and rising provider adoption of telemedicine, increasing consumer demand and patient acceptance, and enhanced quality of care. Besides, the global giant COVID-19 has also been unprecedented and staggering, with telemedicine beholding an assertive demand shock over all regions between the pandemic. Further, the Tele-medicine Industry Worldwide is projected to grow with a staggering CAGR of 21.37% from 2020 to 2026.

COVID-19 Impact on Telemedicine Market

Globally virtual consultations are gracing the new normal: The unforeseen outbreak of the COVID-19 pandemic has brought the whole world to a halt. As hospitals are getting crowded with COVID-19 positive cases, the strain on healthcare staff is rising. Furthermore, the postponement and cancellation of surgeries, including appointments, have minimized patient volume in hospitals and clinics.

In this era of adversities, telemedicine has emerged as a powerful weapon in the war against the COVID-19 pandemic. The global influence of COVID-19 has been unprecedented and tremendous, with telemedicine witnessing a positive demand shock across all regions amid the pandemic. Additionally, most virtual visit service providers are showcasing a tremendous increase in users and subscribers. According to Renub Research Telemedicine Market Size estimated to be US$ 68.36 Billion by 2020.

Globally, the adoption of digital technologies and teleconsultations has become a helpful tool for addressing a health issue. Teleconsultations offer cheaper services and also lessen the work strain on healthcare professionals. This is the primary reason for increasing emphasis by government organizations on deploying digital health technologies, favouring the market's growth rate. Moreover, with social distancing being the new normal, the demand for teleconsultations and digital health services peaked.

By Modality segment, the market bifurcated in Real-Time Telemedicine and Remote Patient Monitoring. The real-time segment expected to witness lucrative growth owing to the drastic rise in the number of e-visits. The developed region such as North America has deemed the maximum revenue share in the global industry due to the continuous research and development initiatives. Furthermore, the regional markets in Europe anticipated showing a similar drift over the forecast period due to growing healthcare awareness coupled with cloud-based technologies acceptance in the country.

In addition, the developing regions such as the Asia Pacific and the Middle East and Africa expected to experience favourable growth in the industry owing to rapid demand for healthcare assistance, especially in the rural areas. Also, the emerging economies in India and China are estimated to witness growth over the next eight-year period. Innovation and development towards telemedicine anticipated enhancing the growth in this region in the coming years.

During the forecasted period, the telemedicine market is expected to become highly competitive as many start-ups seek opportunities in this sector. Globally the market studied is moderately consolidated, owing to a few prominent market players like CEVA, Inc., Eli Lilly and Company, Bayer AG, Merck & Co. Inc. and Teladoc Health, Inc.

Furthermore, the Global Telemedicine Market will become highly competitive with the launch of various platforms and the entry of new players with massive funding.

Renub Research new report titled "Global Telemedicine Market by Types (Products & Services) Application (Teleconsultation, Telepathology, Telecardiology, Telesurgery, Teleradiology, Teledermatology, Telepsychiatry, Others) Modality (Real-Time Telemedicine & Remote Patient Monitoring) End Users (Hospitals, Diagnostics Center, Ambulatory Surgical Center, Specialty Center & Others), Regions (North America, Europe, Asia-Pacifics, Latin America, Middle East & Africa) Company (CEVA Inc, Eli Lilly & Company, Bayer AG, Merck & Co.Inc, Teladoc Health, Inc)" provides a complete analysis of Telemedicine Market Industry Worldwide.

Types Outlook - Market has been covered from 2 viewpoints:

1. Products

2. Services

Application Outlook - Market has been covered from 8 viewpoints:

1. Teleconsultation

2. Telepathology

3. Telecardiology

4. Telesurgery

5. Teleradiology

6. Teledermatology

7. Telepsychiatry

8. Others

Modality Outlook - Market has been covered from 2 viewpoints:

1. Real Time Telemedicine

2. Remote Patient Monitoring

End Users Outlook - Market has been covered from 5 viewpoints:

1. Hospital

2. Diagnostic Center

3. Ambulatory Surgical Center

4. Specialty Center

5. Others

Region Outlook - Market has been covered from 5 viewpoints:

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

All companies have been covered from 3 Viewpoints

  • Overview
  • Recent Development & Strategies
  • Financial Insight

Company Analysis

1. CEVA, Inc.

2. Eli Lilly and Company

3. Bayer AG

4. Merck & Co. Inc

5. Teladoc Health, Inc.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Telemedicine Market

6. Market Share

  • 6.1 By Types
  • 6.2 By Application
  • 6.3 By Modality
  • 6.4 By End Users
  • 6.5 By Region

7. Types- Global Telemedicine Market

  • 7.1 Products
  • 7.2 Services

8. Application - Global Telemedicine Market

  • 8.1 Teleconsultation
  • 8.2 Telepathology
  • 8.3 Telecardiology
  • 8.4 Telesurgery
  • 8.5 Teleradiology
  • 8.6 Teledermatology
  • 8.7 Telepsychiatry
  • 8.8 Others

9. Modality - Global Telemedicine Market

  • 9.1 Real-Time Telemedicine
  • 9.2 Remote Patient Monitoring

10. End User - Global Telemedicine Market

  • 10.1 Hospital
  • 10.2 Diagnostic Center
  • 10.3 Ambulatory Surgical Center
  • 10.4 Specialty Center
  • 10.5 Others

11. Region - Global Telemedicine Market

  • 11.1 North America
  • 11.2 Europe
  • 11.3 Asia Pacific
  • 11.4 Latin America
  • 11.5 Middle East & Africa

12. Company Analysis

  • 12.1 CEVA, Inc.
    • 12.1.1 Overview
    • 12.1.2 Recent Development & Strategies
    • 12.1.3 Financial Insight
  • 12.2 Eli Lilly and Company
    • 12.2.1 Overview
    • 12.2.2 Recent Development & Strategies
    • 12.2.3 Financial Insight
  • 12.3 Bayer AG
    • 12.3.1 Overview
    • 12.3.2 Recent Development & Strategies
    • 12.3.3 Financial Insight
  • 12.4 Merck & Co. Inc
    • 12.4.1 Overview
    • 12.4.2 Recent Development & Strategies
    • 12.4.3 Financial Insight
  • 12.5 Teladoc Health, Inc.
    • 12.5.1 Overview
    • 12.5.2 Recent Development & Strategies
    • 12.5.3 Financial Insight